Healwell AI Past Earnings Performance

Past criteria checks 0/6

Healwell AI's earnings have been declining at an average annual rate of -40.6%, while the Healthcare industry saw earnings growing at 16.2% annually. Revenues have been declining at an average rate of 34.4% per year.

Key information

-40.6%

Earnings growth rate

-25.8%

EPS growth rate

Healthcare Industry Growth-6.7%
Revenue growth rate-34.4%
Return on equity-26.8%
Net Margin-77.8%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Healwell AI Inc. (TSE:AIDX) Shares Slammed 27% But Getting In Cheap Might Be Difficult Regardless

Jan 14
Healwell AI Inc. (TSE:AIDX) Shares Slammed 27% But Getting In Cheap Might Be Difficult Regardless

Investors Appear Satisfied With Healwell AI Inc.'s (TSE:AIDX) Prospects As Shares Rocket 34%

Nov 25
Investors Appear Satisfied With Healwell AI Inc.'s (TSE:AIDX) Prospects As Shares Rocket 34%

Is Healwell AI (TSE:AIDX) A Risky Investment?

Nov 03
Is Healwell AI (TSE:AIDX) A Risky Investment?

Why Investors Shouldn't Be Surprised By Healwell AI Inc.'s (TSE:AIDX) P/S

Sep 10
Why Investors Shouldn't Be Surprised By Healwell AI Inc.'s (TSE:AIDX) P/S

Healwell AI Inc.'s (TSE:AIDX) Intrinsic Value Is Potentially 46% Above Its Share Price

Jun 14
Healwell AI Inc.'s (TSE:AIDX) Intrinsic Value Is Potentially 46% Above Its Share Price

Healwell AI Inc. (TSE:AIDX) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected

Mar 11
Healwell AI Inc. (TSE:AIDX) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected

MCI Onehealth Technologies Inc.'s (TSE:DRDR) Stock Retreats 57% But Revenues Haven't Escaped The Attention Of Investors

Apr 17
MCI Onehealth Technologies Inc.'s (TSE:DRDR) Stock Retreats 57% But Revenues Haven't Escaped The Attention Of Investors

Revenue & Expenses Breakdown

How Healwell AI makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TSX:AIDX Revenue, expenses and earnings (CAD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2426-20353
30 Jun 2414-17234
31 Mar 2410-31194
31 Dec 237-32145
30 Sep 235-27136
30 Jun 237-29137
31 Mar 239-21138
31 Dec 2210-18148
30 Sep 2224-21235
30 Jun 2234-17274
31 Mar 2241-17312
31 Dec 2148-16330
30 Sep 2145-13291
30 Jun 2142-6270
31 Mar 2138-3210
31 Dec 2039-1170
30 Sep 20401100
31 Dec 1946060
31 Dec 1845060
31 Dec 1744050

Quality Earnings: AIDX is currently unprofitable.

Growing Profit Margin: AIDX is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: AIDX is unprofitable, and losses have increased over the past 5 years at a rate of 40.6% per year.

Accelerating Growth: Unable to compare AIDX's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: AIDX is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (11.7%).


Return on Equity

High ROE: AIDX has a negative Return on Equity (-26.78%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/31 20:33
End of Day Share Price 2025/01/31 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Healwell AI Inc. is covered by 9 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Brian KinstlingerAlliance Global Partners
Gabriel LeungBeacon Securities Limited
Douglas TaylorCanaccord Genuity